219 related articles for article (PubMed ID: 10621951)
1. Single photon emission computed tomography of the brain with Tc-99m HMPAO during sumatriptan challenge in obsessive-compulsive disorder: investigating the functional role of the serotonin auto-receptor.
Stein DJ; Van Heerden B; Wessels CJ; Van Kradenburg J; Warwick J; Wasserman HJ
Prog Neuropsychopharmacol Biol Psychiatry; 1999 Aug; 23(6):1079-99. PubMed ID: 10621951
[TBL] [Abstract][Full Text] [Related]
2. Single photon emission computed tomography (SPECT) of anxiety disorders before and after treatment with citalopram.
Carey PD; Warwick J; Niehaus DJ; van der Linden G; van Heerden BB; Harvey BH; Seedat S; Stein DJ
BMC Psychiatry; 2004 Oct; 4():30. PubMed ID: 15482603
[TBL] [Abstract][Full Text] [Related]
3. Serotonergic dissection of obsessive compulsive symptoms: a challenge study with m-chlorophenylpiperazine and sumatriptan.
Gross-Isseroff R; Cohen R; Sasson Y; Voet H; Zohar J
Neuropsychobiology; 2004; 50(3):200-5. PubMed ID: 15365215
[TBL] [Abstract][Full Text] [Related]
4. Effects of meta-chlorophenylpiperazine on cerebral blood flow in obsessive-compulsive disorder and controls.
Ho Pian KL; Westenberg HG; den Boer JA; de Bruin WI; van Rijk PP
Biol Psychiatry; 1998 Sep; 44(5):367-70. PubMed ID: 9755360
[TBL] [Abstract][Full Text] [Related]
5. Sumatriptan (5-HT1D receptor agonist) does not exacerbate symptoms in obsessive compulsive disorder.
Pian KL; Westenberg HG; van Megen HJ; den Boer JA
Psychopharmacology (Berl); 1998 Dec; 140(3):365-70. PubMed ID: 9877016
[TBL] [Abstract][Full Text] [Related]
6. Regional xenon 133 cerebral blood flow and cerebral technetium 99m HMPAO uptake in unmedicated patients with obsessive-compulsive disorder and matched normal control subjects. Determination by high-resolution single-photon emission computed tomography.
Rubin RT; Villanueva-Meyer J; Ananth J; Trajmar PG; Mena I
Arch Gen Psychiatry; 1992 Sep; 49(9):695-702. PubMed ID: 1514874
[TBL] [Abstract][Full Text] [Related]
7. Tc-99m HMPAO brain perfusion SPECT in drug-free obsessive-compulsive patients without depression.
Alptekin K; Degirmenci B; Kivircik B; Durak H; Yemez B; Derebek E; Tunca Z
Psychiatry Res; 2001 Jul; 107(1):51-6. PubMed ID: 11472864
[TBL] [Abstract][Full Text] [Related]
8. Treatment of severe, drug resistant obsessive compulsive disorder with the 5HT1D agonist sumatriptan.
Stern L; Zohar J; Cohen R; Sasson Y
Eur Neuropsychopharmacol; 1998 Dec; 8(4):325-8. PubMed ID: 9928925
[TBL] [Abstract][Full Text] [Related]
9. Zolmitriptan (a 5-HT1B/1D receptor agonist with central action) does not increase symptoms in obsessive compulsive disorder.
Boshuisen ML; den Boer JA
Psychopharmacology (Berl); 2000 Sep; 152(1):74-9. PubMed ID: 11041318
[TBL] [Abstract][Full Text] [Related]
10. Sumatriptan, 5-HT(1D) receptors and obsessive-compulsive disorder.
Koran LM; Pallanti S; Quercioli L
Eur Neuropsychopharmacol; 2001 Apr; 11(2):169-72. PubMed ID: 11313163
[TBL] [Abstract][Full Text] [Related]
11. [Comparison of cerebral blood flow in children with obsessive compulsive disorder and attention deficit hyperactivity disorder].
Oner P; Oner O; Aysev A; Küçük O; Ibiş E
Turk Psikiyatri Derg; 2008; 19(1):13-8. PubMed ID: 18330739
[TBL] [Abstract][Full Text] [Related]
12. Regional cerebral blood flow in obsessive-compulsive disordered patients at rest. Differential correlates with obsessive-compulsive and anxious-avoidant dimensions.
Lucey JV; Costa DC; Blanes T; Busatto GF; Pilowsky LS; Takei N; Marks IM; Ell PJ; Kerwin RW
Br J Psychiatry; 1995 Nov; 167(5):629-34. PubMed ID: 8564319
[TBL] [Abstract][Full Text] [Related]
13. Functional brain imaging in obsessive-compulsive disorder secondary to neurological lesions.
Hugo F; van Heerden B; Zungu-Dirwayi N; Stein DJ
Depress Anxiety; 1999; 10(3):129-36. PubMed ID: 10604087
[TBL] [Abstract][Full Text] [Related]
14. The comparison of pre- and post-treatment (99m)Tc HMPAO brain SPECT images in patients with obsessive-compulsive disorder.
Karadağ F; Kalkan Oğuzhanoğlu N; Yüksel D; Kıraç S; Cura C; Ozdel O; Ateşci F
Psychiatry Res; 2013 Aug; 213(2):169-77. PubMed ID: 23149026
[TBL] [Abstract][Full Text] [Related]
15. Single photon emission computed tomography (SPECT) in obsessive-compulsive disorder before and after treatment with inositol.
Carey PD; Warwick J; Harvey BH; Stein DJ; Seedat S
Metab Brain Dis; 2004 Jun; 19(1-2):125-34. PubMed ID: 15214512
[TBL] [Abstract][Full Text] [Related]
16. m-Chlorophenylpiperazine in patients with obsessive-compulsive disorder: absence of symptom exacerbation.
Goodman WK; McDougle CJ; Price LH; Barr LC; Hills OF; Caplik JF; Charney DS; Heninger GR
Biol Psychiatry; 1995 Aug; 38(3):138-49. PubMed ID: 7578657
[TBL] [Abstract][Full Text] [Related]
17. Regional cerebral blood flow in obsessive-compulsive patients with and without a chronic tic disorder. A SPECT study.
Crespo-Facorro B; Cabranes JA; López-Ibor Alcocer MI; Payá B; Fernández Pérez C; Encinas M; Ayuso Mateos JL; López-Ibor JJ
Eur Arch Psychiatry Clin Neurosci; 1999; 249(3):156-61. PubMed ID: 10433130
[TBL] [Abstract][Full Text] [Related]
18. Right basal ganglion hypoperfusion in obsessive compulsive disorder patients demonstrated by Tc-99m-HMPAO brain perfusion spect: a controlled study.
Topçuoglu V; Cömert B; Karabekiroglu A; Dede F; Erdil TY; Turoglu HT
Int J Neurosci; 2005 Dec; 115(12):1643-55. PubMed ID: 16287631
[TBL] [Abstract][Full Text] [Related]
19. Neuroendocrine and behavioral responses to mCPP in Obsessive-Compulsive Disorder.
Khanna S; John JP; Reddy LP
Psychoneuroendocrinology; 2001 Feb; 26(2):209-23. PubMed ID: 11087965
[TBL] [Abstract][Full Text] [Related]
20. Pharmacotherapy and regional cerebral blood flow in children with obsessive compulsive disorder.
Diler RS; Kibar M; Avci A
Yonsei Med J; 2004 Feb; 45(1):90-9. PubMed ID: 15004874
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
